Number of patients | ||||||||
---|---|---|---|---|---|---|---|---|
25(OH)D level (ng/ml) | Number of patients | Average age ± SD (yrs) | Number of females | Number of pediatric patientsa | Suspected cause of elevated 25(OH)D | Hypercalcemia at time of 25(OH)D measurement | ||
Over-the-counter vitamin D supplements | ||||||||
UIHCb | > 200 | 11 | 43.9 ± 18.3 | 5 (45.4%) | 1 (9.1%) | 4 (36.3%) | 4 (36.3%) | 0 |
151 – 200 | 16 | 58.0 ± 19.6 | 10 (62.5%) | 2 (12.5%) | 4 (25.0%) | 6 (37.5%) | 2 (12.5%) | |
126 – 150 | 24 | 53.1 ± 17.4 | 18 (75.0%) | 0 | 6 (25.0%) | 6 (25.0%) | 1 (4.2%) | |
100 – 125 | 58 | 49.5 ± 20.0 | 38 (65.5%) | 2 (3.4%) | 6 (10.3%) | 4 (6.9%) | 0 | |
WCMC | > 200 | 5 | 58.8 ± 21.5 | 4 (80.0%) | 0 | 1 (20%) | 3 (60%) | 4 (80%) |
151 – 200 | 10 | 46.0 ± 14.9 | 7 (70.0%) | 0 | 3 (30%) | 4 (40%)c | 0 | |
126 – 150 | 6 | 58.8 ± 12.1 | 6 (100.0%) | 1 (16.7%) | 1 (16.7%) | 0d | 0 | |
100 – 125 | 29 | 57.0 ± 16.8 | 25 (86.2%) | 0 | 4 (13.8%) | 10 (34.5%) | 0 |